We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
+3.48%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$419M
AUM Growth
+$8.15M
(+2%)
Cap. Flow
-$63.2M
Cap. Flow
% of AUM
-15.09%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
215
New
79
Increased
32
Reduced
24
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$9.52M |
| 2 |
Waste Management
WM
|
+$9.2M |
| 3 |
PayPal
PYPL
|
+$9.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.79M |
| 5 |
Sysco
SYY
|
+$8.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$30.8M |
| 2 |
Automatic Data Processing
ADP
|
+$25.3M |
| 3 |
Cigna
CI
|
+$21.5M |
| 4 |
Duke Energy
DUK
|
+$13.8M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.89% |
| 2 | Consumer Discretionary | 15.37% |
| 3 | Healthcare | 15.17% |
| 4 | Technology | 13.96% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Teva Pharmaceuticals
TEVA
$40.4B
| – | – |
-14,627
| Closed | -$937K |
|
202
Thermo Fisher Scientific
TMO
$214B
| – | – |
-64,508
| Closed | -$7.21M |
|
203
Trane Technologies
TT
$98.8B
| – | – |
-1,547
| Closed | -$222K |
|
204
UnitedHealth
UNH
$382B
| – | – |
-4,182
| Closed | -$331K |
|
205
United Rentals
URI
$65.7B
| – | – |
-21,312
| Closed | -$1.2M |
|
|
CERN
206
DELISTED
Cerner Corp
CERN
| – | – |
-2,352
| Closed | -$290K |
|
|
RDS.A
207
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-147,673
| Closed | -$6.43M |
|
|
FRAN
208
DELISTED
Francesca's Holdings Corporation
FRAN
| – | – |
-1,809
| Closed | -$1.52M |
|
|
RTN
209
DELISTED
Raytheon Company
RTN
| – | – |
-143,114
| Closed | -$733K |
|
|
MLNT
210
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| – | – |
-84,072
| Closed | -$7.66M |
|
|
BMS
211
DELISTED
Bemis
BMS
| – | – |
-21,168
| Closed | -$1.32M |
|
Similar funds
CM
CFFNO
RIM
TBA
JSC
MSIIA
WHCM
OPFM
Isthmus Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Isthmus Partners held 215 positions worth $419M, up 2% from $411M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Isthmus Partners withdrew a net $63.2M in Q2 2019, closing 77 positions and reducing 24 holdings. Its most notable exit was iShares Core MSCI EAFE ETF, an estimated $9.97M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Isthmus Partners opened a new position in Qualcomm worth $9.89M.
- Isthmus Partners's largest Q2 2019 buy was Qualcomm: 130,003 shares worth $9.89M.
- Isthmus Partners added most to Hanesbrands in Q2 2019, an estimated $6.6M increase.
- Isthmus Partners's biggest Q2 2019 reduction was Fidelity National Information Services, cutting an estimated $30.8M.
- Isthmus Partners fully exited iShares Core MSCI EAFE ETF in Q2 2019, selling an estimated $9.97M.
- Isthmus Partners's ten largest holdings make up 23% of its $419M portfolio in Q2 2019.
- Isthmus Partners opened 79 new positions and closed 77 in Q2 2019.
- Isthmus Partners's portfolio value rose 2% quarter-over-quarter to $419M.
Based on Isthmus Partners's 13F filing for Q2 2019, filed 9 Aug 2019.